1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer

British Journal of Cancer

Volumn 114, Issue 1, 2016, Pages 59-62

  Chan, Angela W ^a   Mercier, Pascal ^b   Schiller, Daniel ^c   Bailey, Robert ^d   Robbins, Sarah ^d   Eurich, Dean T ^b   Sawyer, Michael B ^e   Broadhurst, David ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e CROSS CANCER INSTITUTE   (Canada)

Author keywords

biomarkers; gastric cancer; metabolomics; nuclear magnetic resonance; screening

Indexed keywords

1 METHYLNICOTINAMIDE; 2 FUROYLGLYCINE; 2 HYDROXYISOBUTYRATE; ACONITIC ACID; ALANINE; BIOLOGICAL MARKER; BUTYRIC ACID DERIVATIVE; DIMETHYLAMINE; FORMIC ACID; GLYCINE; INDICAN; N ACETYLSEROTONIN; SEROTONIN; SUCROSE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROMETER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STOMACH CANCER; URINALYSIS; AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; STATISTICAL MODEL; STOMACH NEOPLASMS; URINE;

AGED; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84954364940     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.414     Document Type: Article

References (19)

1. Aa J, Yu L, Sun M, Liu L, Li M, Cao B, Shi J, Xu J, Cheng L, Zhou J, Zheng T, Wang X, Zhao C, Gu R, Zhang F, Shi R, Wang G. (2012). Metabolic features of the tumor microenvironment of gastric cancer and the link to the systemic macroenvironment. Metabolomics. 8(1): 164-173.
2. American Cancer Society. (2015). Survival rates for stomach cancer, by stage [Online]. American Cancer Society. Available at http://www.cancer.org/ cancer/stomachcancer/detailedguide/stomach-cancer-survival-rates (accessed 2015
3. Benjamini YHY. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 57(1): 289-300.
4. Brzozowski T, Konturek PC, Chlopicki S, Sliwowski Z, Pawlik M, Ptak-Belowska A, Kwiecien S, Drozdowicz D, Pajdo R, Slonimska E, Konturek SJ, Pawlik WW. (2008). Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves. J Pharmacol Exp Ther. 326(1): 105-116.
5. Cai Z, Zhao JS, Li JJ, Peng DN, Wang XY, Chen TL, Qiu YP, Chen PP, Li WJ, Xu LY, Li EM, Tam JP, Qi RZ, Jia W, Xie D. (2010) A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics. 9(12): 2617-2628.
6. Cancer Research UK. (2014). Stomach (gastric) cancer [Online]. Cancer Research UK. Available at http://www.cancerresearchuk.org/cancer-info/ cancerstats/incidence/ (accessed web page 2014
7. Chen JL, Tang HQ, Hu JD, Fan J, Hong J, Gu JZ. (2010). Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry. World J Gastroenterol. 16(46): 5874-5880.
8. Correa P. (1988) A human model of gastric carcinogenesis. Cancer Res. 48(13): 3554-3560.
9. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. (2011). Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 40(1): 387-426.
10. Eisner R, Stretch C, Eastman T, Xia J, Hau D, Damaraju S, Greiner R, Wishart D, Baracos V. (2011). Learning to predict cancer-Associated skeletal muscle wasting from 1h-NMR profiles of urinary metabolites. Metabolomics. 7(1): 25-34.
11. Eriksson L, Byrne T, Johansson E, Trygg J, Vikstrom C. (2013). Multi- And Megavariate Data Analysis, Basic Principles and Applications. MKS Umetrics AB: Malmo, Sweden
12. Felig P, Pozefsky T, Marliss E, Cahill Jr GF. (1978). Alanine: key role in gluconeogenesis. Science. 167(3920): 1003-1004.
13. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H, Soga T. (2009). Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69(11): 4918-4925.
14. Hu JD, Tang HQ, Zhang Q, Fan J, Hong J, Gu JZ, Chen JL. (2011). Prediction of gastric cancer metastasis through urinary metabolomic investigation using gc/ms. World J Gastroenterol. 17(6): 727-734.
15. Lu Y, Zhang X, Zhang H, Lan J, Huang G, Varin E, Lincet H, Poulain L, Icard P. (2011). Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma? Anticancer Res. 31(3): 797-805.
16. Sutherland LR, Verhoef M, Wallace JL, Van Rosendaal G, Crutcher R, Meddings JB. (1994) A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet. 343(8904): 998-1000.
17. Swaminathan R, Major P, Snieder H, Spector T. (2000). Serum creatinine and fat-free mass (lean body mass). Clin Chem. 46(10): 1695-1696.
18. Worldwide Cancer Research Fund. (2012). Stomach cancer statistics [Online]. Worldwide Cancer Research Fund. Available at http://www.wcrf.org/int/ cancer-facts-figures/data-specific-cancers/stomach-cancer-statistics (accessed web page 2014
19. Yu L, Aa J, Xu J, Sun M, Qian S, Cheng L, Yang S, Shi R. (2011). Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry. J Gastroenterol Hepatol. 26(8): 1290-1297.